These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7206214)

  • 21. [Clinical experience of amikacin eye lotion (author's transl)].
    Sone Y; Suzuki A; Yamazaki T; Murata M; Komori T; Maekawa I
    Jpn J Antibiot; 1981 Jul; 34(7):1058-62. PubMed ID: 7321183
    [No Abstract]   [Full Text] [Related]  

  • 22. Amikacin pharmacokinetics in the therapy of childhood urinary tract infection.
    Khan AJ; Evans HE; Jhaveri R; Chang CT; Hochstein L
    Pediatrics; 1976 Dec; 58(6):873-6. PubMed ID: 995517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Kinetics of amikacin blood levels in neonates (author's transl)].
    Olivesi A
    Therapie; 1979; 34(4):495-504. PubMed ID: 531781
    [No Abstract]   [Full Text] [Related]  

  • 24. [Experimental studies on topic application of amikacin to the eye (author's transl)].
    Krasemann C; Mester U; Stein HJ
    Arzneimittelforschung; 1978; 28(9):1602-4. PubMed ID: 582564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical experience with amikacin for chronic complicated urinary tract infections in myelopathogenic bladder. Clinical effect against gentamicin-resistant bacteria (author's transl)].
    Konya H; Kuroda J; Iwao N; Morita M
    Jpn J Antibiot; 1978 Jul; 31(7):341-5. PubMed ID: 691255
    [No Abstract]   [Full Text] [Related]  

  • 26. [Comparative clinical effect of amikacin and gentamicin on complicated urinary tract infections by doubld-blind method (author's transl)].
    Nishiura T; Kawada Y; Ichikawa T; Nakano I; Tsuji I; Kumamoto Y; Shishido S
    Nihon Hinyokika Gakkai Zasshi; 1978 Mar; 69(3):381-98. PubMed ID: 351248
    [No Abstract]   [Full Text] [Related]  

  • 27. [Experience in combination therapy with amikacin, mainly by intravenous drip infusion of a large dose, for infections in acute leukaemia patients (author's transl)].
    Koui F; Rai MY; Yorimitsu S; Kitagawa N; Tokioka M; Takahashi I; Kitajima K; Kimura I; Yoshizawa K; Yasui M
    Jpn J Antibiot; 1979 Jun; 32(6):649-54. PubMed ID: 288918
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical experience of amikacin treatment in infantile bacterial infections (author's transl)].
    Chiba S
    Jpn J Antibiot; 1974 Jun; 27(3):389-91. PubMed ID: 4436952
    [No Abstract]   [Full Text] [Related]  

  • 29. [Studies on the toxicity of amikacin (BB-K8), I. Acute toxicity and subacute toxicity in rats (author's transl)].
    Matsuzaki M; Nakamura K; Akutsu S; Sekino M; Hirata A
    Jpn J Antibiot; 1975 Aug; 28(4):415-34. PubMed ID: 1160141
    [No Abstract]   [Full Text] [Related]  

  • 30. [The combination therapy of amikacin and beta-lactam antibiotic in the severe bacterial infections (author's transl)].
    Takigami T
    Jpn J Antibiot; 1982 Feb; 35(2):369-74. PubMed ID: 7087174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amikacin in gram-negative paediatric infections.
    Trujillo H; Manotas R; Ramirez JI; Uribe A; Agudelo N; Zapata CT; Zuluaga AI; de Vidal EL
    J Int Med Res; 1978; 6(4):257-65. PubMed ID: 357227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Studies on the toxicity of amikacin (BB-K8). Chronic toxicity in dogs (author's transl)].
    Matsuzaki M; Yoshida A; Akutsu S; Nakamura K; Sekino M
    Jpn J Antibiot; 1975 Aug; 28(4):485-524. PubMed ID: 1160144
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacokinetics of intravenous amikacin after rapid and slow infusion with special reference to hemodialysis.
    Pechere JC; Dugal R; Pechere MM
    Eur J Drug Metab Pharmacokinet; 1979; 4(1):49-56. PubMed ID: 467467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Studies on the toxicity of amikacin (BB-K8),III. Subacute toxicity of amikacin (BB-K8) in dogs (author's transl)].
    Matsuzaki M; Akutsu S; Yoshida A; Onodera K; Sekino M
    Jpn J Antibiot; 1975 Aug; 28(4):458-84. PubMed ID: 1160143
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical evaluation of amikacin in severe infections with hematological malignant diseases (author's transl)].
    Hotta T; Hirabayashi N; Shimizu K; Utsumi M; Katoh T; Maeda H; Hirano A; Ohnishi K; Murate T; Yamada H
    Jpn J Antibiot; 1981 Nov; 34(11):1457-64. PubMed ID: 7334580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical results with amikacin (BB-K8) in respiratory infections (author's transl)].
    Ito T
    Jpn J Antibiot; 1976 Aug; 29(8):731-4. PubMed ID: 957522
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical evaluation of ototoxicity associated with intravenous drip infusion of amikacin].
    Maeyama T; Hashimoto M; Ogawa K; Hanamure Y; Kiyota R; Kurono Y; Iida F; Ohhori Y; Ogawa K
    Jpn J Antibiot; 1983 Oct; 36(10):2813-9. PubMed ID: 6674516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A case of Klebsiella pneumonia with complication of CO2-narcosis successfully treated with amikacin (author's transl)].
    Nakagami K; Yatani Y; Osakabe Y; Kunieda T; Suzuki H; Satomi T; Saruta E; Noguchi E
    Jpn J Antibiot; 1980 May; 33(5):641-4. PubMed ID: 7001088
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pharmacokinetics and clinical evaluation of BB-K8 in children (author's transl)].
    Yoshioka H; Takimoto M; Nakatsugawa T; Maeda T; Tasaka Y
    Jpn J Antibiot; 1974 Jun; 27(3):382-8. PubMed ID: 4436951
    [No Abstract]   [Full Text] [Related]  

  • 40. [Studies on the toxicity of amikacin (BB-K8).II. Chronic toxicity in rats (author's transl)].
    Matsuzaki M; Nakamura K; Yoshida A; Sekino M; Iimo K
    Jpn J Antibiot; 1975 Aug; 28(4):435-57. PubMed ID: 1160142
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.